0001209191-23-038345.txt : 20230620 0001209191-23-038345.hdr.sgml : 20230620 20230620161044 ACCESSION NUMBER: 0001209191-23-038345 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230615 FILED AS OF DATE: 20230620 DATE AS OF CHANGE: 20230620 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fotopoulos Alexandros CENTRAL INDEX KEY: 0001799814 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39231 FILM NUMBER: 231025138 MAIL ADDRESS: STREET 1: TWO COMMERCE SQUARE, 2001 MARKET STREET STREET 2: 28TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Passage BIO, Inc. CENTRAL INDEX KEY: 0001787297 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 822729751 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE COMMERCE SQUARE STREET 2: 2005 MARKET STREET, 39TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 2678660312 MAIL ADDRESS: STREET 1: ONE COMMERCE SQUARE STREET 2: 2005 MARKET STREET, 39TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19103 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-15 0 0001787297 Passage BIO, Inc. PASG 0001799814 Fotopoulos Alexandros ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 0 1 0 0 Chief Technical Officer 0 Common Stock 2023-06-15 4 M 0 12500 0.00 A 32745 D Common Stock 2023-06-16 4 S 0 4052 0.9325 D 28693 D Restricted Stock Units 2023-06-15 4 M 0 12500 0.00 D Common Stock 12500 25000 D Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs; it does not represent a discretionary trade by the Reporting Person. Pursuant to the Issuer's equity incentive plan, an award recipient's tax withholding obligations must be funded by a "sell to cover" transaction. 1/4 of the RSUs vested on June 15, 2022, and the remainder vested or vests as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date. These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. /s/ Edgar Cale, Attorney-in-Fact 2023-06-20